Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gadducci

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1986
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer]A Gadducci, M Ferdeghini, T Bartolini, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancerA Gadducci, M Ferdeghini, G Rispoli, et al.
European Journal of Gynaecological Oncology|March 23, 2004
An analysis of different approaches to ovarian cysts in ItalyC Romagnolo, T Maggino, P Zola, et al.
European Journal of Gynaecological Oncology|January 1, 1988
Preoperative evaluation of CA 125 and CA 19-9 serum levels in patients with ovarian massesP Fioretti, A Gadducci, M Ferdeghini, et al.
European Journal of Gynaecological Oncology|May 14, 2016
Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy?A Gadducci, M Notarnicola, A Menichetti, et al.
Gynecologic Oncology|November 1, 1996
The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: a CTF studyA Gadducci, F Landoni, T Maggino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literatureA Gadducci, S Cosio, P Zola, et al.
Gynecologic Oncology|February 1, 1996
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian massesA Gadducci, U Baicchi, R Marrai, et al.
Minerva Ginecologica|September 1, 1987
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary]A Gadducci, T Bartolini, M Ferdeghini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 30, 2008
Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancerA Gadducci, R Tana, G Teti, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1986
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer]A Gadducci, M Ferdeghini, T Bartolini, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancerA Gadducci, M Ferdeghini, G Rispoli, et al.
European Journal of Gynaecological Oncology|March 23, 2004
An analysis of different approaches to ovarian cysts in ItalyC Romagnolo, T Maggino, P Zola, et al.
European Journal of Gynaecological Oncology|January 1, 1988
Preoperative evaluation of CA 125 and CA 19-9 serum levels in patients with ovarian massesP Fioretti, A Gadducci, M Ferdeghini, et al.
European Journal of Gynaecological Oncology|May 14, 2016
Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy?A Gadducci, M Notarnicola, A Menichetti, et al.
Gynecologic Oncology|November 1, 1996
The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: a CTF studyA Gadducci, F Landoni, T Maggino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literatureA Gadducci, S Cosio, P Zola, et al.
Gynecologic Oncology|February 1, 1996
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian massesA Gadducci, U Baicchi, R Marrai, et al.
Minerva Ginecologica|September 1, 1987
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary]A Gadducci, T Bartolini, M Ferdeghini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 30, 2008
Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancerA Gadducci, R Tana, G Teti, et al.
Pageof 18